Wolverine – BPC-157 5mg, TB-500 (TB4) 5mg (10mg Blend)

$54.99

  • BPC-157: 5mg
  • TB-500 (TB4): 5mg
  • Total Material: 10mg
  • Vial Size: 3mL
  • BPC-157 Molecular Formula: C62H98N16O22
  • BPC-157 Molecular Weight: 1419.556 g/mol
  • BPC-157 PubChem CID: 9941957
  • BPC-157 CAS: 137525-51-0
  • TB-500 Molecular Formula: C212H350N56O78S
  • TB-500 Molecular Weight: 4963 g/mol
  • TB-500 PubChem CID: 16132341
  • TB-500 CAS: 77591-33-4
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPBPCTB10 Categories: , Tags: , ,
Description

Wolverine BPC 157 5mg / TB-500 5mg – Advanced 10mg Research Blend

Wolverine BPC 157 5mg / TB-500 5mg is a two-component peptide research blend containing 10mg total specified material in a 3mL vial. Equal listed quantities of BPC-157 and TB-500 (TB4) provide a clearly documented combination for controlled laboratory investigation.

Each component has its own supplied sequence, molecular formula, molecular weight, PubChem identifier, and CAS number for research identification.

Wolverine BPC 157 Research Blend Overview

The formulation contains two independently specified peptide materials:

Specification BPC-157 TB-500 (TB4)
Quantity 5mg 5mg
Molecular Formula C62H98N16O22 C212H350N56O78S
Molecular Weight 1419.556 g/mol 4963 g/mol
PubChem CID 9941957 16132341
CAS Number 137525-51-0 77591-33-4

Total Material: 10mg
Vial Size: 3mL

These quantities describe the supplied product. They do not establish a human dose, administration schedule, or universal experimental concentration.

BPC-157 5mg Molecular Specifications

The first component contains 5mg of BPC-157.

Its supplied sequence is:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

The molecular formula is:

C62H98N16O22

The supplied molecular weight is 1419.556 g/mol, PubChem CID is 9941957, and CAS number is 137525-51-0.

Researchers can examine records associated with the supplied formula through the PubChem molecular formula search for C62H98N16O22.

These characteristics provide multiple reference points for material identification and research documentation.

TB-500 5mg Molecular Specifications

The second component contains 5mg of TB-500 (TB4).

Its supplied sequence is:

Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH

The supplied molecular formula is:

C212H350N56O78S

The molecular weight is 4963 g/mol, with PubChem CID 16132341 and CAS number 77591-33-4.

Researchers can examine records associated with this formula through the PubChem molecular formula search for C212H350N56O78S.

Wolverine BPC 157 10mg Research Formulation

The Wolverine BPC 157 formulation contains:

BPC-157: 5mg
TB-500 (TB4): 5mg

Together, these components provide 10mg total specified research material.

Research involving the complete blend should be distinguished from experiments examining either component independently. Results involving one isolated material should not automatically be generalized to a two-component research system.

Molecular Identification

Accurate identification of the Wolverine formulation requires consideration of both peptide components.

The BPC-157 component is documented through its sequence, C62H98N16O22 formula, 1419.556 g/mol molecular weight, PubChem CID 9941957, and CAS 137525-51-0.

The TB-500 component is independently documented by its sequence, C212H350N56O78S formula, 4963 g/mol molecular weight, PubChem CID 16132341, and CAS 77591-33-4.

These specifications provide researchers with multiple reference points when documenting the blend.

BPC Wolverine and Search Terminology

Search users may encounter alternative phrases such as bpc wolverine, wolverine bpc, wolverine bp157, or related terminology.

These phrases represent search variations rather than separate molecular specifications.

For controlled research, the identity of each component should be established through the supplied sequence, molecular formula, molecular weight, database identifiers, and material quantity rather than keyword formatting alone.

Peptides Wolverine Research Context

The phrase peptides wolverine reflects broader search interest surrounding the combination product.

The supplied formulation specifically contains two separately documented materials at equal listed quantities.

Relevant research considerations may include:

  • Identity of each component
  • Individual material quantity
  • Molecular characteristics
  • Experimental concentration
  • Research model
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Reproducibility

Experimental conclusions should remain limited to the research conditions under which observations are generated.

3mL Research Vial

This Wolverine BPC 157 blend is supplied in a 3mL vial.

Vial capacity is a physical product specification. It does not independently establish final preparation volume, experimental concentration, or administration quantity.

No solvent, reconstitution procedure, storage requirement, or experimental concentration was supplied with the provided product data.

Those parameters are therefore not being inferred.

Laboratory Research Documentation

Research records for the formulation may include:

BPC-157: 5mg
TB-500 (TB4): 5mg
Total Material: 10mg
Vial Capacity: 3mL

Component-specific documentation can additionally include:

  • Molecular sequence
  • Molecular formula
  • Molecular weight
  • PubChem CID
  • CAS number

Experiment-specific records may include concentration, research model, controls, methodology, observation conditions, analytical procedures, and measured endpoints.

Evaluating Scientific Literature

When comparing this formulation with scientific literature, researchers should distinguish between studies involving individual components and studies involving combination systems.

Important factors include:

  • Exact molecular identity
  • Individual components
  • Experimental concentration
  • Research model
  • Study design
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Measured endpoints

Research involving BPC-157 independently should not automatically be interpreted as evidence concerning the complete blend.

The same distinction applies when evaluating literature involving TB-500 or TB4 independently.

Related OROS Research Materials

Researchers can review REGEN – ARA-290 / BPC-157 / TB-500 as another multi-component research formulation.

Another combination is RENU – BPC-157 / Cartalax / TB-500.

The catalog also includes the Wolverine – BPC-157 5mg / TB-500 5mg listing associated with this strength.

Researchers looking at the higher-strength formulation can review Wolverine – BPC-157 10mg / TB-500 10mg.

Each formulation has separate quantities and should be documented independently.

Scientific Research Resources

Researchers can use PubChem to investigate available molecular records and chemical identifiers.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

Researchers should verify the exact material, research model, experimental concentration, methodology, controls, and endpoints before comparing findings across studies.

Research FAQ

What is Wolverine BPC 157?

Wolverine BPC 157 is the product designation used here for a research blend containing 5mg BPC-157 and 5mg TB-500 (TB4).

How much total material is supplied?

The two listed components provide 10mg total specified research material.

What is the BPC-157 sequence?

The supplied sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

What is the BPC-157 PubChem CID?

The supplied PubChem CID is 9941957.

What is the TB-500 PubChem CID?

The supplied PubChem CID for the second component is 16132341.

What are the supplied CAS numbers?

The supplied CAS number for BPC-157 is 137525-51-0, while TB-500 (TB4) is listed with CAS 77591-33-4.

What size vial is supplied?

The research blend is supplied in a 3mL vial.

Does the vial size establish research concentration?

No. The 3mL capacity does not independently establish an experimental concentration or preparation volume.

Research Use Disclaimer

This Wolverine BPC 157 / TB-500 blend is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantities and vial capacity are research specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, athletic performance enhancement, bodybuilding, or veterinary application.

Additional information
Net Weight

10mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Wolverine – BPC-157 5mg, TB-500 (TB4) 5mg (10mg Blend)”

Your email address will not be published. Required fields are marked *